Scandinavia's Medicon Valley is experiencing a spurt of funding, prompted by a combination of government and private capital. Obtaining sufficient capital resources for the initial financing of ...
Hosted on MSN
Krystal Biotech projects EU and Japan launches for VYJUVEK in 2025, targeting $1B global peak sales
CEO Krish Krishnan highlighted 2024 as a strong year, driven by the continued success of the VYJUVEK launch in the U.S., which is tracking as a top-tier rare disease launch. He emphasized the ...
A project to turn Michigan into a biotechnology powerhouse is being gutted to help keep the state out of debt. The Life Sciences Corridor — established in 1999 with settlement money from a multistate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback